Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.

Roush DJ, Myrold A, Burnham MS, And JV, Hughes JV.

Biotechnol Prog. 2015 Jan-Feb;31(1):135-44. doi: 10.1002/btpr.2020. Epub 2014 Nov 29.

PMID:
25395156
2.

Effectiveness of various processing steps for viral clearance of therapeutic proteins: database analyses of commonly used steps.

Cipriano D, Burnham M, Hughes JV.

Methods Mol Biol. 2012;899:277-92. doi: 10.1007/978-1-61779-921-1_18.

PMID:
22735960
3.

Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.

Zoltick PW, Chirmule N, Schnell MA, Gao GP, Hughes JV, Wilson JM.

J Virol. 2001 Jun;75(11):5222-9.

4.

Adenoviral-mediated suicide gene therapy for ovarian cancer.

Alvarez RD, Gomez-Navarro J, Wang M, Barnes MN, Strong TV, Arani RB, Arafat W, Hughes JV, Siegal GP, Curiel DT.

Mol Ther. 2000 Nov;2(5):524-30.

5.

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM.

Mol Ther. 2000 Apr;1(4):323-9.

6.

Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.

Chirmule N, Raper SE, Burkly L, Thomas D, Tazelaar J, Hughes JV, Wilson JM.

J Virol. 2000 Apr;74(7):3345-52.

7.

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle.

Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P, Wilson JM.

J Virol. 2000 Mar;74(5):2420-5.

8.

A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.

Zuckerman JB, Robinson CB, McCoy KS, Shell R, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Brown-Parr EC, Hughes JV, Tazelaar J, Baker C, Goldman MJ, Wilson JM.

Hum Gene Ther. 1999 Dec 10;10(18):2973-85.

PMID:
10609658
9.

Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.

Chirmule N, Truneh A, Haecker SE, Tazelaar J, Gao Gp, Raper SE, Hughes JV, Wilson JM.

J Immunol. 1999 Jul 1;163(1):448-55.

10.

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.

Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM.

Hum Gene Ther. 1999 Feb 10;10(3):463-75.

PMID:
10048398
11.

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

Ye X, Rivera VM, Zoltick P, Cerasoli F Jr, Schnell MA, Gao G, Hughes JV, Gilman M, Wilson JM.

Science. 1999 Jan 1;283(5398):88-91.

12.

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus.

Gao GP, Qu G, Faust LZ, Engdahl RK, Xiao W, Hughes JV, Zoltick PW, Wilson JM.

Hum Gene Ther. 1998 Nov 1;9(16):2353-62.

PMID:
9829534
13.
14.

Validation of retroviral detection for rodent cell-derived products and gene therapy applications.

Hughes JV, Messner K, Burnham M, Patel D, White EM.

Dev Biol Stand. 1996;88:297-304.

PMID:
9119153
15.

Allograft safety: viral inactivation with bone demineralization.

Scarborough NL, White EM, Hughes JV, Manrique AJ, Poser JW.

Contemp Orthop. 1995 Oct;31(4):257-61.

PMID:
10163469
16.

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization.

Michne WF, Schroeder JD, Bailey TR, Neumann HC, Cooke D, Young DC, Hughes JV, Kingsley SD, Ryan KA, Putz HS, et al.

J Med Chem. 1995 Aug 18;38(17):3197-206.

PMID:
7650672
17.

Keto/enol epoxy steroids: a new structural class of HIV-1 Tat inhibitors.

Michne WF, Schroeder JD, Bailey TR, Young DC, Hughes JV, Dutko FJ.

J Med Chem. 1993 Sep 3;36(18):2701-2. No abstract available.

PMID:
8410982
18.

An inactivated hepatitis A viral vaccine of cell culture origin.

Provost PJ, Hughes JV, Miller WJ, Giesa PA, Banker FS, Emini EA.

J Med Virol. 1986 May;19(1):23-31.

PMID:
3009703
19.

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Emini EA, Hughes JV, Perlow DS, Boger J.

J Virol. 1985 Sep;55(3):836-9.

21.

Molecular cloning and partial sequencing of hepatitis A viral cDNA.

Linemeyer DL, Menke JG, Martin-Gallardo A, Hughes JV, Young A, Mitra SW.

J Virol. 1985 May;54(2):247-55.

22.
23.

Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Hughes JV, Stanton LW, Tomassini JE, Long WJ, Scolnick EM.

J Virol. 1984 Nov;52(2):465-73.

24.

Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon.

Takemoto DJ, Jilka C, Rockenbach S, Hughes JV.

Prep Biochem. 1983;13(4):371-93.

PMID:
6196772
25.

Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon.

Takemoto DJ, Jilka C, Rockenbach S, Hughes JV.

Prep Biochem. 1983;13(5):397-421.

PMID:
6142453
26.

Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus.

Dille BJ, Hughes JV, Johnson TC, Rabinowitz SG, Dal Canto MC.

J Gen Virol. 1981 Aug;55(Pt 2):343-54.

PMID:
6270268
27.

RNA degradation defect in central nervous system isolates of vesicular stomatitis virus.

Hughes JV, Johnson TC.

J Gen Virol. 1981 Aug;55(Pt 2):53-64.

PMID:
6169798
28.
29.

Isolation of the glycoprotein of vesicular stomatitis virus and its binding to cell surfaces.

Thimmig RL, Hughes JV, Kinders RJ, Milenkovic AG, Johnson TC.

J Gen Virol. 1980 Oct;50(2):279-91.

PMID:
6257823
30.

Glycopeptides from brain inhibit rates of polypeptide chain elongation.

Kinders RJ, Hughes JV, Johnson TC.

J Biol Chem. 1980 Jul 10;255(13):6368-72.

31.

Viral nucleocapsid melting to measure protein: RNA interactions.

Hughes JV, Johnson TC.

Biochem Biophys Res Commun. 1980 Jun 16;94(3):777-84. No abstract available.

PMID:
6249292
32.

Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus.

Hughes JV, Dille BJ, Thimmig RL, Johnson TC, Rabinowitz SG, Dal Canto MC.

J Virol. 1979 Jun;30(3):883-90.

34.
35.

Abnormal amino acid metabolism and brain protein synthesis during neural development.

Hughes JV, Johnson TC.

Neurochem Res. 1978 Aug;3(4):381-99. No abstract available.

PMID:
34113
36.

Experimentally induced and natural recovery from the effects of phenylalanine on brain protein synthesis.

Hughes JV, Johnson TC.

Biochim Biophys Acta. 1978 Feb 16;517(2):473-85.

PMID:
245312
38.
39.

The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro.

Hughes JV, Johnson TC.

J Neurochem. 1976 Jun;26(6):1105-13. No abstract available.

PMID:
932716

Supplemental Content

Loading ...
Support Center